EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 25, Issue 7, Pages 968-982
Publisher
Springer Nature
Online
2012-04-27
DOI
10.1038/modpathol.2012.52
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma
- (2011) S. D. Dojcinov et al. BLOOD
- miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy
- (2011) S. Montes-Moreno et al. BLOOD
- Genomic aberrations affecting the outcome of immunodeficiency-related diffuse large B-cell lymphoma
- (2011) Ivo Kwee et al. LEUKEMIA & LYMPHOMA
- Geographic variation in the prevalence of Epstein–Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population
- (2011) Annegret Hofscheier et al. MODERN PATHOLOGY
- EBV Positive Mucocutaneous Ulcer—A Study of 26 Cases Associated With Various Sources of Immunosuppression
- (2010) Stefan D. Dojcinov et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab
- (2010) Paul N. Meyer et al. JOURNAL OF CLINICAL ONCOLOGY
- Presence of monoclonal T-cell populations in B-cell post-transplant lymphoproliferative disorders
- (2010) Hazem A H Ibrahim et al. MODERN PATHOLOGY
- Oncogenic Activation of NF- B
- (2010) L. M. Staudt Cold Spring Harbor Perspectives in Biology
- Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008
- (2009) J. I. Cohen et al. ANNALS OF ONCOLOGY
- Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma
- (2009) K. Dunleavy et al. BLOOD
- Genome wide DNA-profiling of HIV-related B-cell lymphomas
- (2009) Daniela Capello et al. BRITISH JOURNAL OF HAEMATOLOGY
- A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
- (2009) W. W.L. Choi et al. CLINICAL CANCER RESEARCH
- Epstein-Barr virus–positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype
- (2009) Sarah E. Gibson et al. HUMAN PATHOLOGY
- Epstein–Barr virus-positive diffuse large B-cell lymphoma carrying a t(9;14)(p13;q32) translocation
- (2009) Hitoshi Ohno et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
- (2009) Mara Compagno et al. NATURE
- Age-related EBV-associated B-cell lymphoproliferative disorders: Diagnostic approach to a newly recognized clinicopathological entity
- (2009) Yoshie Shimoyama et al. PATHOLOGY INTERNATIONAL
- Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients
- (2008) N. Asano et al. BLOOD
- Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: Special references to lymphomas surrounding this newly recognized clinicopathologic disease
- (2008) Yoshie Shimoyama et al. CANCER SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started